Current Drug Discovery Technologies
Title: Editorial [Hot Topic: “Supramolecular Transmembrane Nanocarriers for Targeted Therapeutics” (Guest Editor: Grzegorz Bazylak) ]
Volume: 5 Issue: 2
Author(s): Grzegorz Bazylak
Affiliation:
Export Options
About this article
Cite this article as:
Bazylak Grzegorz, Editorial [Hot Topic: “Supramolecular Transmembrane Nanocarriers for Targeted Therapeutics” (Guest Editor: Grzegorz Bazylak) ], Current Drug Discovery Technologies 2008; 5 (2) . https://dx.doi.org/10.2174/157016308784746229
DOI https://dx.doi.org/10.2174/157016308784746229 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
Related Journals
Related Books
14
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardiorenal Consequences of Atherosclerosis and Statins Therapy: From the Past to the Future
Current Pharmaceutical Design Development and a Practical Synthesis of Nepafenac Intermediate via Modified Gassman Reaction
Letters in Organic Chemistry Biomarkers in Atrial Fibrillation and Heart Failure
Current Medicinal Chemistry Neuropathic Pain: Is the End of Suffering Starting in the Gene Therapy?
Current Drug Targets An Interplay between Obesity and Inflammation in Gestational Diabetes Mellitus
Current Pharmaceutical Biotechnology Preface
Current Pharmaceutical Design Dendritic Cells and their Receptors in Antitumor Immune Response
Current Molecular Medicine Soy Phytoestrogens and Breast Cancer Chemoprevention: Molecular Mechanisms
Current Nutrition & Food Science Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Preface [ Hot Topic: Autoimmunity (Executive Editor : Dorothea Stahl)]
Current Pharmaceutical Design The Non-Canonical IκB Kinases IKKε and TBK1 as Potential Targets for the Development of Novel Therapeutic Drugs
Current Molecular Medicine Editorial (Thematic Issues: Basic and Clinical Aspects of Melatonin in the Gastrointestinal Tract. New Advancements and Future Perspectives)
Current Pharmaceutical Design Curcuminoids Plus Piperine Modulate Adipokines in Type 2 Diabetes Mellitus
Current Clinical Pharmacology The Immunoregulatory Activity of Mesenchymal Stem Cells: ‘State of Art’ and ‘Future Avenues’
Current Medicinal Chemistry Use of Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Relation to Cardiovascular Events. A Systematic Pharmacoepidemiological Review
Current Vascular Pharmacology Immune Response and Immunotherapy: Live Attenuated Listeria monocytogenes (Lm)-LLO Immunotherapy for the Treatment of Prostate Cancer
Current Cancer Therapy Reviews Effectors of Fatty Acid Oxidation Reduction: Promising New Anti-Ischaemic Agents
Current Pharmaceutical Design Development and Biocompatibility Analysis of NBD Peptide Sustained- Release Microsphere Scaffold Nanoparticle SP-Sr-CaS/NBD
Current Drug Delivery Apoptosis in Obstructive Nephropathy
Current Pediatric Reviews Preface
Mini-Reviews in Medicinal Chemistry